McRae Andrew D, Ackroyd-Stolarz Stacy, Weijer Charles
Department of Emergency Medicine, Queen's University, Kingston, Ontario, Canada.
Acad Emerg Med. 2005 Nov;12(11):1104-12. doi: 10.1197/j.aem.2005.04.005. Epub 2005 Sep 15.
To apply component analysis, a structured approach to the ethical analysis of risks and potential benefits in research, to published emergency research using a waiver of/exception from informed consent. The hypothesis was that component analysis could be used with a high degree of interrater reliability, and that the vast majority of emergency research would comply with a minimal-risk threshold.
A Medline search and manual search were done to identify studies using a waiver of/exception from informed consent published between July 1996 and December 2000. A review panel of physicians and bioethicists independently classified nontherapeutic procedures in each study as minimal risk, probably minimal risk, or probably more than minimal risk.
Seventy studies using a waiver of/exception from informed consent were identified. A majority of reviewers classified nontherapeutic procedures in 62 studies (88.6%) as minimal risk. Reviewers classified nontherapeutic procedures in six studies (8.6%) as minimal risk or probably minimal risk. In two studies (2.9%), nontherapeutic procedures were classified as probably more than minimal risk. The intraclass correlation coefficient was 0.89 (95% CI = 0.85 to 0.93), indicating very high interrater reliability.
Component analysis can be used with high reliability to review emergency research and may improve the consistency of institutional review board review of emergency research. The vast majority of published emergency research performed using a waiver of/exception from consent complies with a properly-applied minimal-risk threshold. A minimal-risk threshold for nontherapeutic procedures protects subjects better than current U.S. regulations while permitting important emergency research to continue.
应用成分分析法(一种对研究中的风险和潜在益处进行伦理分析的结构化方法),对已发表的使用知情同意豁免/例外的紧急研究进行分析。假设是成分分析法可在评分者间具有高度可靠性的情况下使用,并且绝大多数紧急研究将符合最低风险阈值。
进行了Medline检索和手工检索,以识别1996年7月至2000年12月期间发表的使用知情同意豁免/例外的研究。一个由医生和生物伦理学家组成的评审小组独立地将每项研究中的非治疗性程序分类为最低风险、可能最低风险或可能高于最低风险。
识别出70项使用知情同意豁免/例外的研究。大多数评审者将62项研究(88.6%)中的非治疗性程序分类为最低风险。评审者将6项研究(8.6%)中的非治疗性程序分类为最低风险或可能最低风险。在2项研究(2.9%)中,非治疗性程序被分类为可能高于最低风险。组内相关系数为0.89(95%CI = 0.85至0.93),表明评分者间可靠性非常高。
成分分析法可高度可靠地用于审查紧急研究,并可能提高机构审查委员会对紧急研究审查的一致性。绝大多数已发表的使用同意豁免/例外进行的紧急研究符合正确应用的最低风险阈值。非治疗性程序的最低风险阈值比美国现行法规更能保护受试者,同时允许重要的紧急研究继续进行。